Modulation of neurogenesis by PDE inhibition
US7985756B2 · kind B2 · utility
28Cited by
204References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2006 |
| Grant date | Jul 26, 2011 |
| Priority date | — |
| Expiry date | May 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a PDE agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.